These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 38416279

  • 1. Herpes Zoster Recurrence: A Narrative Review of the Literature.
    Parikh R, Spence O, Giannelos N, Kaan I.
    Dermatol Ther (Heidelb); 2024 Mar; 14(3):569-592. PubMed ID: 38416279
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
    Safonova E, Yawn BP, Welte T, Wang C.
    Respir Res; 2023 Jan 28; 24(1):35. PubMed ID: 36709298
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies.
    Mwakingwe-Omari A, Lecrenier N, Naficy A, Curran D, Posiuniene I.
    Hum Vaccin Immunother; 2023 Dec 15; 19(3):2278362. PubMed ID: 37965770
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A systematic literature review to assess the burden of herpes zoster disease in China.
    Yin D, Van Oorschot D, Jiang N, Marijam A, Saha D, Wu Z, Tang H, Diaz-Decaro J, Watson P, Xie X, Ren Y, He Y, Feng Y.
    Expert Rev Anti Infect Ther; 2021 Feb 15; 19(2):165-179. PubMed ID: 32997550
    [Abstract] [Full Text] [Related]

  • 11. Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007-2018.
    Batram M, Witte J, Schwarz M, Hain J, Ultsch B, Steinmann M, Bhavsar A, Wutzler P, Criée CP, Hermann C, Wahle K, Füchtenbusch M, Greiner W.
    Dermatol Ther (Heidelb); 2021 Jun 15; 11(3):1009-1026. PubMed ID: 33959878
    [Abstract] [Full Text] [Related]

  • 12. Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study.
    Oh H, Tan C, Williams C, Giannelos N, Ng C.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2348839. PubMed ID: 38804600
    [Abstract] [Full Text] [Related]

  • 13. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ.
    Ophthalmology; 2008 Feb 31; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [Abstract] [Full Text] [Related]

  • 14. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
    Pirrotta P, Tavares-Da-Silva F, Co M, Lecrenier N, Hervé C, Stegmann JU.
    Drug Saf; 2021 Dec 31; 44(12):1341-1353. PubMed ID: 34622421
    [Abstract] [Full Text] [Related]

  • 15. A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations.
    Parikh R, Widenmaier R, Lecrenier N.
    Expert Rev Vaccines; 2021 Sep 31; 20(9):1065-1075. PubMed ID: 34311643
    [Abstract] [Full Text] [Related]

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T, Shen H, Deng H, Pan H, He Q, Ni H, Tao J, Liu S, Xu L, Yao M.
    J Proteomics; 2020 Aug 15; 225():103879. PubMed ID: 32585426
    [Abstract] [Full Text] [Related]

  • 19. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL, Reuter-Monslow MA, Sei J, Durr E, Davis CW, Chang C, McCausland M, Wieland A, Krah D, Rouphael N, Mehta AK, Mulligan MJ, Pulendran B, Ahmed R, Vora KA.
    J Virol; 2018 Jul 15; 92(14):. PubMed ID: 29743372
    [Abstract] [Full Text] [Related]

  • 20. How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
    Han R, Gomez JA, de Veras B, Pinto T, Guzman-Holst A, Nieto J, van Oorschot DAM.
    Hum Vaccin Immunother; 2023 Dec 31; 19(1):2164144. PubMed ID: 36821856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.